Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Catanzaro
Clinical trial register · Italy

Clinical Trials in Catanzaro, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6778 matching records held by the registry are in this view. Synced 08 Oct 2026, 03:19 UTC
6778
Studies in scope
all four open statuses
4069
Recruiting now
open to new participants
1018
Lead sponsors
across recruiting studies
Top sites
Milan 2843 Bologna 1305 Roma 1274 Naples 984 Rome 967
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca9 Novo Nordisk A/S6 IRCCS Azienda Ospedaliero-Universitaria di Bologna5 Hoffmann-La Roche4 Gilead Sciences4
Site location
Milan2843 Bologna1305 Roma1274 Naples984 Rome967
All 489 locations
Target enrolment
to

Trials with a site in Catanzaro

111 of 6778 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Not yet open
Novo Nordisk A/S
Phase 3
8,500
Chieti, Bari, Castellana Grotte (BA), Catanzaro, Cosenza, Naples, Salerno, Ferrara
2026-10-26
Recruiting
Novo Nordisk A/S
Phase 3
1,778
Chieti, Catanzaro, Naples, Ravenna, Chiavari, Milan, Roma, Lucca
2026-08-24
Recruiting
Istituto per la Ricerca e l'Innovazione Biomedica
Observational
200
Catanzaro
2026-07-01
Recruiting
Assessment of Motor Reserve in the Preclinical Stages of Dementia
NCT07634055Mild Cognitive Impairment (MCI)
Istituto per la Ricerca e l'Innovazione Biomedica
Observational
200
Catanzaro
2026-07
Not yet open
Standardized Italian netwoRk Enrolling iNdividuals With Islet-Autoantibodies
NCT07503366Type 1 Diabetes (T1D), Autoantibodies, Hyperglycemia, Impaired Glucose Tolerance (Prediabetes)
Società Italiana di Endocrinologia e Diabetologia Pediatrica
Observational
300
Ancona, Bari, Bolzano, Caserta, Catanzaro, Crotone, Florence, L’Aquila
2026-05
Recruiting
Octapharma
Phase 4
28
Catanzaro, Palermo
2026-04
Recruiting
Hoffmann-La Roche
Phase 3
1,600
Bergamo, Catanzaro, Bologna, Rome, Milan, Palermo, Perugia
2026-03-23
Recruiting
Gruppo Oncologico Italia Meridionale
Phase 2
150
Alessandria, Ancona, Aviano, Caserta, Castellana Grotte, Catania, Catanzaro, Florence
2026-03-20
Recruiting
Hoffmann-La Roche
Phase 3
2,000
Bergamo, Bari, Catanzaro, Bologna, Rome, San Donato Milanese (MI), Palermo, Pisa
2026-03-16
Recruiting
argenx
Observational
100
Acquaviva delle Fonti, Ancona, Bari, Bergamo, Bologna, Catanzaro, Florence, Genova
2026-02-25
Recruiting
Federico II University
Phase 2/3
100
Catanzaro, Latina, Naples
2026-02
Recruiting
University Hospital, Grenoble
Observational
1,600
Bari, Catanzaro, Rovigo, Sanremo, Torino, Trento, Trieste, Venice
2026-01-15
Active, closed
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
1,200
Bologna, Cagliari, Catanzaro, Florence, Milan, Palermo, Potenza, Roma
2025-12-09
Active, closed
Appropriate Management of Hepatic EncePhalopaThy AmonG cirrhOtic patieNts Admitted to Internal Medicine
NCT07727070Cirrhoses, Liver, Portal Hypertension Related to Cirrhosis, Liver Stiffness, Hepatic Encephalopathy
Fadoi Foundation, Italy
Observational
400
Ariccia, Arzignano, Assisi, Bologna, Bolzano, Brindisi, Casale Monferrato, Catanzaro
2025-12-05
Recruiting
Janssen Research & Development, LLC
Observational
380
Avellino, Aviano, Bari, Bergamo, Brescia, Candiolo, Catania, Catanzaro
2025-12-03
Active, closed
University of Catanzaro
Observational
1,500
Catanzaro
2025-11-01
Active, closed
Platelet-Rich Fibrin as an Antibiotic Delivery Vehicle in Mandibular Third Molar Surgery
NCT07764757Facial Swelling, Tooth Position Anomalies, Tooth, Impacted, Tooth Extraction Status Nos
DrugPlatelet-Rich Fibrin
Amerigo Giudice
Not applicable
31
Catanzaro
2025-11-01
Recruiting
University of Campania Luigi Vanvitelli
Phase 3
480
Ancona, Avellino, Aviano, Bari, Brescia, Castellana Grotte, Catania, Catanzaro
2025-10-01
Active, closed
Istituto per la Ricerca e l'Innovazione Biomedica
Not applicable
46
Catanzaro
2025-09-01
Not yet open
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Observational
100
Rome, Catania, Catanzaro, Reggio Calabria
2025-09-01
Active, closed
Novo Nordisk A/S
Observational
245
Milan, Turin, Livorno, Lucca, Bergamo, Catanzaro, Naples, Perugia
2025-08-28
Recruiting
Novo Nordisk A/S
Phase 4
586
Bari, Catanzaro, Naples, Rome, Milan, Messina, Palermo, Fermo
2025-08-15
Recruiting
Boehringer Ingelheim
Phase 3
11,800
Acquaviva Delle Fonti (BA), Bergamo, Brescia, Catania, Catanzaro, Chieti, Cona (FE), Coppito (AQ)
2025-07-22
Active, closed
REal-life ON PARKinson's - ITaly (REONPARK-IT)
NCT07403799Parkinson Disease
Bial - Portela C S.A.
Observational
200
Bari, Brescia, Cagliari, Catanzaro, Chieti, Genova, Messina, Milan
2025-07-08
Active, closed
Upstream Bio Inc.
Phase 2
396
Catanzaro
2025-05-21
Active, closed
Eli Lilly and Company
Phase 3
905
Bologna, Catanzaro, Florence, Milan, Naples, Padova, Roma, Torino
2025-04-25
Recruiting
Epygenix
Phase 3
260
Genoa, Pozzilli, Catanzaro, Florence, Milan
2025-04-09
Recruiting
AstraZeneca
Phase 3
400
Bari, Bergamo, Brescia, Cagliari, Catanzaro, Genoa, Milan, Modena
2025-03-28
Recruiting
FB Vision S.p.A
Not applicable
74
Cagliari, Catanzaro
2025-03-26
Recruiting
Hoffmann-La Roche
Phase 3
600
Bari, Catanzaro, Naples, Rome, Milan, Monza MI, Pavia, Rho
2025-03-17
Recruiting
Swedish Orphan Biovitrum
Phase 3
104
Catanzaro, Florence, Milan, Naples, Parma, Rome, Rozzano, Vicenza
2025-03-06
Not yet open
Measurement of the Optic Nerve Diameter in Different Healthcare Operators
NCT06830460Healthy Volunteer, Healthy Volunteer Study
University Magna Graecia
Not applicable
40
Catanzaro
2025-03-01
Active, closed
Epidyolex® in Lennox Gastaut, Dravet Syndrome and Tuberous Sclerosis Complex: an Observational Study in ITALY
NCT05485831Lennox Gastaut Syndrome, Dravet Syndrome, Tuberous Sclerosis Complex
DrugCannabidiol
Jazz Pharmaceuticals
Observational
111
Bologna, Catanzaro, Chieti, Florence, Genova, Messina, Milan, Naples
2025-02-24
Recruiting
Diamagnetic Therapy in Pain and Inflammation
NCT06844552Pain, Inflammation
University of Catanzaro
Observational
120
Catanzaro
2025-02-19
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
60
Bologna, Bari, Cagliari, Catania, Catanzaro, Florence, Genova, Messina
2025-02-12
Recruiting
IRCCS San Raffaele Roma
Not applicable
130
Rome, San Vito sullo Ionio, Costa Masnaga, Fiorenzuola d'Arda, Passignano sul Trasimeno, Ummbertide, Bergamo, Catanzaro
2025-02-06
Recruiting
Università Vita-Salute San Raffaele
Not applicable
400
Catanzaro, Florence, Genova, Milan, Monza, Naples, Padova, Udine
2025-01-30
Recruiting
Università Vita-Salute San Raffaele
Not applicable
800
Catanzaro, Milan
2025-01-27
Recruiting
Cardiometabolic Risk of Obese Subjects: Cross-sectional Study
NCT06714058Obesity and Obesity-related Medical Conditions, Cardiovascular Risk, Genetics
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
240
Bologna, Catanzaro
2024-11-30
Active, closed
AbbVie
Observational
1,314
Milan, Naples, Turin, Rome, Ancona, Bari, Catanzaro, Pavia
2024-11-26
Recruiting
INTERconNEcT-Eds: a Guided Self-help Mobile App to Improve Outcome in Eating Disorders
NCT06551974Eating Disorder Symptom, Eating Disorders, Eating Behavior
University of Palermo
Not applicable
242
Catanzaro
2024-11-15
Recruiting
IRCCS San Raffaele
Observational
530
Catanzaro, Milan
2024-11-07
Recruiting
Abivax S.A.
Phase 2
212
Bologna, Catanzaro, Milan, Negrar, Pavia, Roma, Rozzano, San Giovanni Rotondo
2024-10-30
Recruiting
Merck Sharp & Dohme LLC
Phase 3
680
Catanzaro, Ravenna, Rome, Milan, Naples, Padova, Verona
2024-10-21
Active, closed
Evaluation of the Effect of Lomitapide Treatment on Major Adverse Cardiovascular Events (MACE) in Patients With Homozygous Familial Hypercholesterolemia
NCT06832371Homozygous Familial Hypercholesterolemia (HoFH), Major Adverse Cardiovascular Events (MACE), Dyslipidemia
Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi)
Observational
73
Catanzaro, Caserta, Naples, Bologna, Ferrara, Modena, Genova, Catania
2024-09-09
Recruiting
AbbVie
Phase 2
590
Monserrato, San Giovanni Rotondo, Rozzano, Milan, Rome, Turin, Negrar, Catanzaro
2024-09-04
Recruiting
Fondazione Don Carlo Gnocchi ETS
Not applicable
596
Acerenza, Bari, Bergamo, Catania, Catanzaro, Crotone, Foggia, Genova
2024-08-12
Recruiting
Comparison of Piezoelectric and Conventional Surgery for Germectomy of the Lower Third Molar
NCT06778590Tooth Disease, Piezoelectric Technique, Tooth Impacted, Tooth Extraction Status Nos
Amerigo Giudice
Not applicable
22
Catanzaro
2024-08-01
Active, closed
Novartis Pharmaceuticals
Observational
379
Ancona, L’Aquila, Bari, Bergamo, Chieti, Catania, Catanzaro, Cona
2024-07-30
By invitation
Biohaven Therapeutics Ltd.
Phase 2
660
Chieti, Catanzaro, Naples, Bologna, Rome, Genoa, Milan, Pavia
2024-07-30
Recruiting
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Phase 2
385
Bologna, Brescia, Catanzaro, Milan, Negrar, Padova, Roma, Rozzano
2024-07-18
Active, closed
ELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer
NCT06328738HER2-positive Breast Cancer, HER2-positive Gastric Cancer, HER2 Positive Solid Tumors, HER2 Amplification
DrugsELVN-002·Eribulin·Leucovorin·Trastuzumab
Enliven Therapeutics
Phase 1
275
Catanzaro, Milan, Monza, Pisa, Reggio Emilia, Rome
2024-05-30
Recruiting
Daiichi Sankyo
Phase 3
540
Bari, Bergamo, Brescia, Catania, Catanzaro, Genova, Milan, Monza
2024-05-21
Active, closed
Biohaven Therapeutics Ltd.
Phase 2/3
390
Chieti, Catanzaro, Naples, Bologna, Rome, Genoa, Milan, Pavia
2024-05-13
Recruiting
AstraZeneca
Phase 3
3,850
Acquaviva delle Fonti, Bari, Bergamo, Brescia, Catania, Catanzaro, Cona, Cortona
2024-04-12
Active, closed
AstraZeneca
Phase 3
2,554
Bologna, Catanzaro, Chiavari, Desio, Milan, Naples, Parma, Rozzano
2024-03-29
Active, closed
Gilead Sciences
Phase 2
228
Bologna, Cagliari, Catanzaro, Milan, Negrar, Padova, Palermo, Roma
2024-03-27
Recruiting
Amryt Pharma
Phase 4
12
Bologna, Catanzaro, Novara, Pisa, Udine
2024-02-08
Active, closed
DualityBio Inc.
Phase 3
541
Bergamo, Brescia, Catania, Catanzaro, Milan, Pavia, Verona, Naples
2024-01-18
Recruiting
Colorado Prevention Center
Phase 3
5,200
Bergamo, Catanzaro, Genova, Varese, Ancona, Brescia
2024-01-17
Recruiting
Merck Sharp & Dohme LLC
Phase 3
614
Bari, Meldola, Udine, Milan, Bergamo, Catanzaro, Florence, Roma
2023-12-15
Active, closed
Gilead Sciences
Phase 2
176
Catanzaro, Milan, Roma, Rozzano
2023-12-05
Recruiting
The Viability Control of Human Endothelial Cells Before Keratoplasty (V-CHECK) Study
NCT05847387Corneal Transplant Failure, Corneal Endothelial Cell Loss
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Observational
135
Brescia, Bologna, Catanzaro, Roma, Venice, Vicenza
2023-12-01
Recruiting
Octapharma
Phase 4
28
Catanzaro, Florence, Milan
2023-11-28
Recruiting
Imaging Biomarkers to Stratify the Risk of Barotrauma in ARDS
NCT05816954Acute Respiratory Distress Syndrome, Barotrauma
Università Vita-Salute San Raffaele
Observational
100
Catanzaro, Milan
2023-08-30
Active, closed
AstraZeneca
Observational
151
Alessandria, Ancona, Bari, Barletta, Brindisi, Campobasso, Catania, Catanzaro
2023-08-08
Active, closed
Amgen
Phase 3
509
Bergamo, Catanzaro, Genova, Meldola (FC), Orbassano, Roma
2023-05-31
Active, closed
Gilead Sciences
Phase 3
654
Ancona AN, Aviano, Bergamo, Bologna, Catania, Catanzaro, Genova GE, Milan
2023-05-08
Active, closed
University Hospital of Ferrara
Not applicable
1,823
Bologna, Ferrara, Bolzano, Catanzaro, Cosenza, Baggiovara, Piacenza, Parma
2023-05-08
Active, closed
Janssen Research & Development, LLC
Phase 3
20,284
Arezzo, Aversa, Bergamo, Bologna, Caserta, Catania, Catanzaro, Ferrara
2023-04-11
Recruiting
AstraZeneca
Phase 3
4,300
Bari, Catania, Catanzaro, Florence, Genova, Grosseto, Milan, Modena
2023-03-31
Active, closed
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
NCT05739383Primary Prevention of Atherosclerotic Cardiovascular Disease
DrugInclisiran
Novartis Pharmaceuticals
Phase 3
14,012
Ancona, Brescia, Caserta, Chieti, Catanzaro, Florence, Chiavari, Genova
2023-03-09
Recruiting
Practice of Oxygenation and Respiratory Support During Fiberoptic Bronchoscopy
NCT05681962Acute Respiratory Failure, Pneumonia, Lung Cancer, Fibrosis Lung
University Magna Graecia
Observational
10,000
Catanzaro
2023-02-15
Active, closed
Cenobamate in Adults With Focal-Onset Seizures
NCT05859854Epilepsy, Focal-Onset Seizure, Neurological Disorder
Aziende Chimiche Riunite Angelini Francesco S.p.A
Observational
936
Bari, Catanzaro, Pozzilli, Pavia, Roma, Torino, Conegliano, Udine
2023-01-24
Active, closed
Bristol-Myers Squibb
Phase 3
606
Meldola, Milan, Rozzano, Bologna, Catanzaro, Lecce, Pisa, Udine
2023-01-10
Recruiting
Anthos Therapeutics, Inc.
Phase 3
2,500
Ancona, Bologna, Brescia, Cagliari, Caserta, Catanzaro, Cinisello Balsamo, Florence
2022-12-27
Active, closed
Amgen
Phase 3
7,297
Arzignano, Bologna, Brescia, Caserta, Catania, Catanzaro, Cona FE, Florence
2022-12-14
Active, closed
Sanofi
Phase 2
187
Bolzano, Milan, Rozzano, Rome, Catanzaro, Palermo, Pavia
2022-11-25
Active, closed
A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products
NCT05476926Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion, Branch Retinal Vein Occlusion
DrugsVabysmo·Faricimab
Hoffmann-La Roche
Observational
6,000
Chieti, Bari, Catanzaro, Naples, Udine, Rome, Genoa, Bergamo
2022-11-21
Active, closed
Novo Nordisk A/S
Phase 3
3,400
Bari, Catanzaro, San Donato Milanese (MI), Roma, Siena, Bologna, Catania, Padova
2022-11-01
Active, closed
Amgen
Phase 1
184
Catanzaro, Monza (MB), Rome
2022-08-24
Active, closed
Eli Lilly and Company
Phase 4
780
Bari, Naples, Milan, Moncalieri, Olbia, Palermo, Pisa, Catanzaro
2022-08-01
Active, closed
AstraZeneca
Phase 3
644
Borgo San Lorenzo, Catanzaro, Genova, Livorno, Milan, Modena, Naples, Province of Macerata
2022-05-16
Recruiting
AstraZeneca
Phase 2
630
Aviano, Brescia, Catanzaro, Florence, Genova, Meldola, Milan, Monza
2022-04-14
Recruiting
De Sire Alessandro
Not applicable
57
Catanzaro
2022-03-17
Recruiting
Meyer Children's Hospital IRCCS
Observational
290
Florence, Bari, Brescia, Catanzaro, Lecce, Milan, Padova, Pavia
2022-02-10
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
800
Chieti, Potenza, Caserta, Catanzaro, Cosenza, Bologna, Genova, Bergamo
2022-01-26
Recruiting
UCB Biopharma SRL
Phase 3
350
Catanzaro, Genova, Milan, Pavia, Roma
2021-12-07
Active, closed
Gilead Sciences
Phase 3
603
Bergamo, Brescia, Catania, Catanzaro, Cremona, Milan, Pavia, Roma
2021-11-17
Active, closed
Loxo Oncology, Inc.
Phase 3
600
Bologna, Catanzaro, Cona, Cuneo, Florence, Meldola, Milan, Modena
2021-09-20
Active, closed
Janssen Pharmaceutica N.V., Belgium
Observational
1,314
Bari, Campobasso, Catanzaro, Florence, Naples, Palermo, Pisa, Potenza
2021-08-25
By invitation
Viatris Innovation GmbH
Phase 3
25,000
Arezzo, Bologna, Caserta, Catania, Catanzaro, Cona, Florence, Messina
2021-08-14
Active, closed
Regeneron Pharmaceuticals
Observational
717
Rozzano, Catania, Pisa, Siena, Padova, Catanzaro, Genova, Rome
2021-08-12
Active, closed
Daiichi Sankyo
Phase 3
490
Barone, Candiolo, Catanzaro, Milan, Modena, Naples, Padua, Pisa
2021-05-21
Active, closed
Novo Nordisk A/S
Phase 3
1,205
Catanzaro, San Giovanni Rotondo, Palermo, Bologna, Florence, Foggia, Milan, Roma
2021-04-01
Recruiting
Antimicrobial Combination Therapy for Treatment of Enterococcus Faecalis Bacteremia
NCT06833593Enterococcus Faecalis Infection, Blood Stream Infection, Gut Microbiomes
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
510
Bologna, Catanzaro, Milan
2021-02-06
Recruiting
AutoInflammatory Disease Alliance Registry (AIDA)
NCT05200715Hereditary Autoinflammatory Diseases, Schnitzler Syndrome, Behcet Syndrome, PFAPA Syndrome
University of Siena
Observational
3,500
Siena, Bari, Bolzano, Brescia, Cagliari, Catania, Catanzaro, Chieti
2020-08-06
Active, closed
Gruppo Italiano Malattie EMatologiche dell'Adulto
Observational
321
Cona, Alessandria, Bari, Cagliari, Catania, Catanzaro, Cosenza, Florence
2020-07-24
Active, closed
AstraZeneca
Phase 2
240
Bologna, Catanzaro, Meldola, Messina, Milan, Monza, Naples, Roma
2020-04-22
Active, closed
AstraZeneca
Phase 3
818
Bergamo, Candiolo, Catanzaro, Livorno, Meldola, Milan, Modena, Naples
2020-04-16
Active, closed
GlaxoSmithKline
Phase 3
325
Bologna, Brescia, Catanzaro, Milan, Pavia, Perugia, Ravenna, Roma
2020-04-02
Recruiting
Federico II University
Observational
5,000
Arzignano, Bari, Caserta, Catanzaro, Eboli, Foggia, Genova, Lecce
2020-03-07
Active, closed
SyncAV Post-Market Trial
NCT04100148Congestive Heart Failure
Abbott Medical Devices
Not applicable
1,686
Bari, Carbonara di Bari, Catanzaro, Avellino
2019-10-03
Active, closed
Xenon Pharmaceuticals Inc.
Phase 2
325
Bologna, Catanzaro, Milan, Pavia, Pisa, Reggio Calabria, Roma
2019-01-30
Active, closed
Travere Therapeutics, Inc.
Phase 3
406
Ranica, Milan, Bari, Catania, Catanzaro, Lecco, Modena, Pavia
2018-12-11
Active, closed
Eli Lilly and Company
Phase 3
1,058
Catanzaro, Genova, Pisa, Rho, Roma, Rome, Rozzano, Torino
2018-07-18
Recruiting
Martin Schrappe
Phase 3
5,000
Ancona, Bari, Bergamo, Bologna, Brescia, Cagliari, Catania, Catanzaro
2018-07-15
Active, closed
AbbVie
Phase 3
747
Bologna, Rozzano, Milan, Rome, Negrar, Catania, Catanzaro, Genova
2018-03-21
Active, closed
Gruppo Italiano Malattie EMatologiche dell'Adulto
Observational
530
Ancona, Bologna, Brindisi, Cagliari, Catania, Catanzaro, Cona, Cosenza
2017-11-13
Active, closed
Trial of Low Dose Tamoxifen in Women With Breast Intraepithelial Neoplasia - Long Term Follow-up
NCT01357772Carcinoma, Intraductal, Noninfiltrating, Recurrence, Local Neoplasm, Breast Neoplasms, Atypical Hyperplasia
DrugTamoxifen
Andrea DeCensi
Phase 3
500
Tortona, Meldola, Carpi, Bari, Catanzaro, Genoa, Milan, Modena
2008-11-12
Active, closed
Genentech, Inc.
Phase 2
378
Potenza, Catanzaro, Naples, Meldola, Parma, Aviano (PN), Udine, Milan
2008-10-16
Rows per page Showing 1–111 of 111
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 October 2026. https://priyalifescience.com/clinical-trials-italy/city/catanzaro

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,778 studies in total at the last sync on 08 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 111 of those studies with a site in Catanzaro.

How many clinical trials are recruiting in Catanzaro?

53 of the 111 studies on this page are recruiting new participants as of the 08 Oct 2026, 03:19 UTC sync. A further 4 have not yet opened recruitment, 52 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Catanzaro), 111 studies
PhaseStudiesRecruitingShare
Phase 3411836.9%
Observational351731.5%
Not applicable13811.7%
Phase 213511.7%
Phase 4544.5%
Phase 1201.8%
Phase 2/3211.8%

Most active sponsors

Lead sponsors with the most studies (Catanzaro)
Lead sponsorStudiesRecruiting
AstraZeneca94
Novo Nordisk A/S62
IRCCS Azienda Ospedaliero-Universitaria di Bologna54
Gilead Sciences40
Hoffmann-La Roche43
AbbVie31
Amgen30
Eli Lilly and Company30
Istituto per la Ricerca e l'Innovazione Biomedica32
Università Vita-Salute San Raffaele33
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.